<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00956267</url>
  </required_header>
  <id_info>
    <org_study_id>MU- 094</org_study_id>
    <secondary_id>FMH-052-K</secondary_id>
    <nct_id>NCT00956267</nct_id>
  </id_info>
  <brief_title>Letrozole or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome.</brief_title>
  <official_title>Letrozole Versus Laparoscopic Ovarian Diathermy for Ovulation Induction in Clomiphene-resistant Women With Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare and determine the efficacy of letrozole
      administration to that of laparoscopic ovarian diathermy (LOD) in infertile women with
      Polycystic ovary syndrome(PCOS)not responding to treatment with Clomiphene alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the letrozole group, withdrawal bleeding was achieved using 10 mg of dydrogesterone
      tablets for 10 days before stimulation, then 2.5 mg of letrozole oral tablets (Femara;
      Novartis Pharma Services, Switzerland) daily from day 3 of the menses for 5 days up to six
      cycles. All patients in the control group underwent laparoscopic ovarian diathermy, then
      followed up for 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>occurrence of ovulation and midcycle endometrial thickness (mm).</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>occurrence of pregnancy, miscarriage, multiple pregnancy and live birth rates.</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">260</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>Letrozole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.5 mg letrozole oral tablets daily from day 3 of the menses for 5 days up to 6 cycles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic ovarian diathermy (LOD)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Three-puncture technique. Each ovary was cauterized at four points, each for 4 seconds at 40 W for a depth of 4 mm with a mixed current, using an monopolar electrosurgical needle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Letrozole</intervention_name>
    <description>2.5 mg letrozole oral tablets daily from day 3 of the menses for 5 days up to 6 cycles</description>
    <arm_group_label>Letrozole</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic ovarian diathermy (LOD)</intervention_name>
    <description>Three-puncture technique. Each ovary was cauterized at four points, each for 4 seconds at 40 W for a depth of 4 mm with a mixed current, using an monopolar electrosurgical needle.</description>
    <arm_group_label>Laparoscopic ovarian diathermy (LOD)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CC resistant PCOS

        Exclusion Criteria:

          -  Congenital adrenal hyperplasia

          -  Cushing syndrome

          -  Androgen secreting tumors
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hatem Abu Hashim, MD. MRCOG</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abdel Maged Mashaly, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura University Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed Badawy, MD.PhD.</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mansoura University Hospitals,OB/GYN department</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia Governorate</state>
        <zip>35511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril. 2006 Feb;85(2):277-84. Review.</citation>
    <PMID>16595197</PMID>
  </reference>
  <reference>
    <citation>Bayram N, van Wely M, Kaaijk EM, Bossuyt PM, van der Veen F. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ. 2004 Jan 24;328(7433):192.</citation>
    <PMID>14739186</PMID>
  </reference>
  <reference>
    <citation>Farquhar C, Lilford RJ, Marjoribanks J, Vandekerckhove P. Laparoscopic 'drilling' by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001122. Review. Update in: Cochrane Database Syst Rev. 2012;6:CD001122.</citation>
    <PMID>17636653</PMID>
  </reference>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2009</study_first_submitted>
  <study_first_submitted_qc>August 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2009</study_first_posted>
  <last_update_submitted>August 10, 2009</last_update_submitted>
  <last_update_submitted_qc>August 10, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Hatem Abu Hashim, Associate Prof. of OB/GYN</name_title>
    <organization>Mansoura Faculty of Medicine, Mansoura University.</organization>
  </responsible_party>
  <keyword>Polycystic ovary syndrome</keyword>
  <keyword>clomiphene resistance</keyword>
  <keyword>letrozole</keyword>
  <keyword>Laparoscopic ovarian diathermy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Letrozole</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

